Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review
Sign Up to like & getrecommendations! Published in 2020 at "CNS Drugs"
DOI: 10.1007/s40263-020-00734-4
Abstract: Introduction Cognitive impairment is prevalent and debilitating among persons with multiple sclerosis (MS). While many pharmacologic treatments have shown good efficacy in reducing clinical relapses, brain lesions, and improving certain physical symptoms, their efficacy for… read more here.
Keywords: systematic review; efficacy; multiple sclerosis; pharmacologic treatments ... See more keywords
Non-pharmacologic and pharmacologic treatments for anxiety in long-term care: a systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Age and ageing"
DOI: 10.1093/ageing/afac195
Abstract: BACKGROUND older adults living in long-term care (LTC) commonly suffer from anxiety symptoms and disorders. We completed a systematic review and meta-analysis to identify efficacious treatments for anxiety symptoms for older adults living in LTC.… read more here.
Keywords: pharmacologic treatments; non pharmacologic; treatments anxiety; anxiety symptoms ... See more keywords
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Neurology"
DOI: 10.1097/wco.0000000000001029
Abstract: Purpose of review Summarize evidence on Developmental and Epileptic Encephalopathies (DEEs) treatments focusing on new and emerging pharmacologic therapies (see Video, http://links.lww.com/CONR/A61, Supplementary Digital Content 1, which provides an overview of the review). Recent findings… read more here.
Keywords: pharmacologic treatments; emerging pharmacologic; new emerging; developmental epileptic ... See more keywords
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Geriatrics Society"
DOI: 10.1111/jgs.15966
Abstract: To assess adverse effects of pharmacologic antidepressants for treatment of major depressive disorder (MDD) in adults 65 years of age or older. read more here.
Keywords: depression older; major depression; effects pharmacologic; adverse effects ... See more keywords